Functional characterization of endothelin receptors in hypertensive resistance vessels
- 1 January 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (1) , 45-52
- https://doi.org/10.1097/00004872-199917010-00008
Abstract
The physiological and pathophysiological functions of endothelin-1 in modulating the regional blood flow of normal and spontaneously hypertensive rats (SHR) were studied in the perfused mesenteric vascular bed, a useful model for investigating resistance vessels. We used 12-week-old SHR and Wistar–Kyoto (WKY) rats. Endothelin A (ETA) receptor responsiveness was evaluated by endothelin-1 (0.2–2 μmol/l) concentration–response curves, and repeated in the presence of indomethacin and the ETA and endothelin B (ETB) receptor antagonists BQ-485 and BQ-788, respectively. ETB receptor responsiveness was tested by sarafotoxin S6c concentration–response curves, obtained in the noradrenaline-precontracted mesenteric vascular bed, and repeated after treatment with BQ-788 and after endothelial denudation. In both groups, endothelin-1 induced concentration-dependent contraction; SHR exhibited a markedly increased maximal effect compared with WKY rats (P 2 The higher vasoconstriction induced by endothelin-1 in SHR may be related to a greater number of available ETA receptors, due to the presence of an ETA receptor subtype. This mechanism may be linked to the production of prostanoids that add to the direct endothelin-1-evoked vasoconstriction. These results, together with the lack of relaxation in response to sarafotoxin S6c in SHR, suggest that an imbalance in the endothelin-1 ability to induce both contraction and relaxation is present in SHR with sustained hypertension, manifesting as a greater contractile effect evoked in this strain.Keywords
This publication has 27 references indexed in Scilit:
- Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor BlockadeCirculation, 1998
- Possible Role of Endothelin in Endothelial Regulation of Vascular ToneAnnual Review of Pharmacology and Toxicology, 1995
- Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub‐typeBritish Journal of Pharmacology, 1995
- Characterization of Contractile Endothelin and Angiotensin Receptors in Human Resistance Arteries: Evidence for Two Endothelin and One Angiotensin ReceptorBiochemical and Biophysical Research Communications, 1994
- Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?Trends in Pharmacological Sciences, 1994
- The Endothelin Family of Peptides: Local Hormones with Diverse Roles in Health and Disease?Clinical Science, 1993
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.Proceedings of the National Academy of Sciences, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988